‘Mistrust’ of Palantir may affect NHS research, says health minister
Health innovation minister James Frith said concern about Palantir could reduce patients’ willingness to share data with the NHS. His comments followed figures showing that tens of thousands of patients had withdrawn their data from research projects, prompting concern about the company’s work with the health service.
Health innovation minister James Frith said he was concerned that “mistrust” of the US defence and health technology company Palantir could affect people’s willingness to share data with the NHS.
His comments followed new figures showing that tens of thousands of patients had withdrawn their data from use in research projects. The figures have prompted concern about Palantir’s work with the NHS.
THE QUESTIONS THIS EVENT LEAVES BEHIND
What specific concerns are driving patients to withdraw their data?
How are NHS research projects affected when patients opt out?
What safeguards govern Palantir’s work with the NHS?
How might public trust change if more patients withhold their data?
YOUR QUESTION
Does this story leave you with another question?
Send us the question the report did not answer. It may become the next question IAQ investigates.
GLOBAL CURIOSITY MAP · JULY 2026